Document:

EX-10.36

 Exhibit 10.36 

THE AZEK COMPANY INC. 

NONQUALIFIED STOCK OPTION GRANT 

(Option Award for AOT Building Products, L.P. Profits Interests) 

THIS STOCK OPTION GRANT (the “Agreement”), is made effective as of the date set forth on the Company signature page (the
“Signature Page”) attached hereto (the “Date of Grant”), by and among The AZEK Company Inc., a Delaware corporation (together with its successors and assigns, the “Company”), and the participant
identified on the Signature Page attached hereto (“Participant”). 
 R E C I T A L S: 

WHEREAS, Participant holds the number of Profits Interests (the “Profits Interests”) of AOT Building Products, L.P., a
Delaware limited partnership (“Parent”) specified on the Signature Page, which Profits Interests were issued pursuant to the Amended and Restated Agreement of Limited Partnership of Parent (as amended from time to time, the
“LP Agreement”) and one or more LP Interest Agreements (collectively, the “LP Interest Agreements”); 

WHEREAS, all of the outstanding Common Interests of Parent are being exchanged (the “Common Exchange”) for shares
(“Shares”) of common stock, par value $0.001, of the Company effective prior to or substantially concurrent with the consummation of the initial public offering (the “IPO”) of the common stock (the date such Common
Exchange becomes effective, the “Exchange Date”); 
 WHEREAS, all of Participant’s Profits Interests are being
exchanged (the “Exchange”) for Shares effective as of the Exchange Date; 
 WHEREAS, Participant is being granted options
to purchase Shares (the “Options”) in order to restore the leverage that Participant had with respect to Participant’s Profits Interests prior to the Exchange; 

WHEREAS, the Company has adopted The AZEK Company Inc. 2020 Omnibus Incentive Compensation Plan (the “Plan”), the terms of
which Plan are incorporated herein by reference and made a part of this Agreement, and capitalized terms not otherwise defined herein shall have the same meaning as in the Plan; and 

WHEREAS, immediately following the IPO, Participant shall receive a number of Options, as described herein and otherwise subject to the terms
hereof and the Plan. 
 NOW THEREFORE, in consideration of the mutual covenants hereinafter set forth, the parties hereto agree as follows:

 1. Grant of Options. Subject to the terms and conditions of the Plan and the terms and conditions set forth in this Agreement and
effective as of the Date of Grant, the Company and Parent will grant a number of Options calculated by the Compensation Committee of the Board of Directors of the Company (the “Committee”) in accordance with this
Section 1, which will be specified on the Signature Page. In the event the IPO is not consummated within 30 days following the Date of Grant, this Award of Options shall be null and void and of no further force or effect.

 (a) The number of Options shall be calculated by the Committee in its reasonable good faith discretion, such that the aggregate number of
Options equals (a) the Adjusted Profits Interests Number (as defined below), less (b) the number of Shares (including any Shares subject to restrictions) granted pursuant to the Exchange, rounded to the nearest whole Share. The
Options shall vest and become nonforfeitable vested Options in accordance with Schedule I attached hereto. 

 (b) For purposes of this Agreement, the “Adjusted Profits Interests Number”
is the total number of Profits Interests (whether vested or unvested), as set forth on the Signature Page, multiplied by the number of Shares for which each Common Interest of Parent is exchanged in the Common Exchange. By way of example
only, if each Common Interest of Parent is exchanged for two Shares, and the Participant holds 10 Profits Interests, then the Adjusted Profits Interests Number is 20. 

2. Exercise Price; Duration. The price at which Participant will be entitled to purchase Shares upon the exercise of the Options will be
the price at which Shares are offered in the IPO (the “Exercise Price”), subject to adjustment as set forth in the Plan. The Options will be exercisable to the extent and in the manner provided in Section 2.3.5 of the Plan for
a period of ten (10) years from the Date of Grant (the “Expiration Date”); provided, however, that the Options may be earlier terminated as provided herein. Notwithstanding the foregoing, (i) if
Participant’s employment is terminated due to death or Disability (as defined in the Plan), each outstanding vested Option will remain exercisable for one year thereafter (but in no event beyond the Expiration Date), (ii) if Participant’s
employment is terminated for Cause (as defined in the Plan), each outstanding vested Option will expire and immediately cease to be exercisable upon the date of the termination and (iii) if Participant’s employment with the Company Group
is terminated for any other reason, each outstanding vested Option will remain exercisable for ninety (90) days thereafter (but in no event beyond the Expiration Date). 

3. Prior Agreements. Participant acknowledges that (a) the unvested Profits Interests are subject to vesting conditions and
(b) the Profits Interests are subject to a clawback that requires, in the event of the Participant’s willful or intentional material breach of a non-competition,
non-solicitation or non-disclosure covenant (or failure to correct a material breach of any such covenant after written notice of such breach), that the Participant will
automatically forfeit the Profits Interests and repay amounts distributed in respect of any Profits Interests in the 24 months prior to such breach (which forfeiture and repayment will be in addition to any other rights that the Company and its
affiliates have). Participant acknowledges and agrees that (x) the Options will remain subject to the vesting conditions that applied to the unvested Profits Interests, as provided in Schedule I and (y) the Shares underlying the Options
will remain subject to the clawback terms as applied to the Profits Interests. 
 4. Manner of Exercise and Payment. 

(a) Subject to the terms and conditions of this Agreement, the Options may be exercised by delivery of written notice to the Company in the
manner prescribed in Section 2.3.5 of the Plan and as otherwise set forth by the Committee from time to time. Any exercisable portion of the Option or the entire Option, if then wholly exercisable, may be exercised in whole or in part, provided
that partial exercise will be for whole Shares only. 
 (b) Upon exercise of the Options pursuant to Section 4(a), unless otherwise
determined by the Committee, the Company will withhold a number of Shares otherwise deliverable to Participant to pay (i) the full purchase price for the Shares in respect of which the Option is being exercised and (ii) an amount necessary
to satisfy applicable U.S. and non-U.S. Federal, state or local tax or other withholding requirements, if any (“Withholding Taxes”) in accordance with Section 3.2 of the Plan (or such
amount which would not result in adverse consequences under generally accepted accounting principals), unless otherwise agreed to in writing by Participant and the Company. The number of Shares to be withheld or otherwise used for payment will be
calculated using the closing price per Share on the New York Stock Exchange (or other principal exchange on which the Shares then trade) on the date of determination, and will be rounded up to the nearest whole Share. 

  
 -2- 

 (c) Upon receipt of the notice of exercise and any payment or other documentation as may be
necessary pursuant to this Section 4 relating to the Shares in respect of which the Option is being exercised, the Company will, subject to the Plan and this Agreement, take such action as may be necessary to effect the transfer to Participant
of the number of Shares as to which such exercise was effective. Notwithstanding the foregoing, unless otherwise determined by the Committee, Participant may otherwise elect to make all or a portion of such payments in cash, check, cash equivalent,
and/or Shares, or as provided in Section 3.2 of the Plan. 
 (d) Participant will not be deemed to be the holder of, or to have any of
the rights and privileges of a stockholder of the Company (including the right to vote or receive dividends) in respect of, Shares purchased upon exercise of the Option until (i) the Option has been exercised pursuant to the terms of this
Agreement and Participant has paid the full purchase price for the number of Shares in respect of which the Option was exercised and any applicable Withholding Taxes and (ii) the Company has issued the Shares in connection with such exercise.

 5. No Right to Continued Employment. Neither the Plan nor this Agreement nor Participant’s receipt of the Options hereunder
shall impose any obligation on the Company or any Affiliate to continue the employment or engagement of Participant. Further, the Company or any Affiliate (as applicable) may at any time terminate the employment or engagement of such Participant,
free from any liability or claim under the Plan or this Agreement, except as otherwise expressly provided herein. 
 6. Assignment
Restrictions. 
 (a) The Options may not, at any time, be Assigned and any such purported Assignment shall be void and unenforceable
against the Company or any Affiliate; provided, that the designation of a beneficiary shall not constitute an Assignment. 
 (b) The
Options shall be subject to the lock-up restrictions provided to Participant separately (which are enclosed as Exhibit A), to which Participant agrees by signing this Agreement, and any other agreements
to which Participant is or may become a party, including as applicable the Registration Rights Agreement by and among the Company, Ares Corporate Opportunities Fund IV, L.P., Ontario Teachers’ Pension Plan Board and certain stockholders. 

(c) “Assign” or “Assignment” shall mean (in either the noun or the verb form, including with respect to the
verb form, all conjugations thereof within their correlative meanings) with respect to any security, the gift, sale, assignment, transfer, pledge, hypothecation or other disposition (whether for or without consideration, whether directly or
indirectly, and whether voluntary, involuntary or by operation of law) of such security or any interest therein. 
 7. Securities Laws;
Cooperation. Upon the delivery of any Shares, Participant will make or enter into such written representations, warranties and agreements as the Committee may reasonably request in order to comply with applicable securities laws, the Plan or
with this Agreement. Participant further agrees to cooperate with the Company in taking any action reasonably necessary or advisable to consummate the transactions contemplated by this Agreement. 

8. Notices. Any notice necessary under this Agreement shall be addressed to the Company in care of its Chief Legal Officer at the
principal executive office of the Company and to Participant at the address appearing in the personnel records of the Company for such Participant or to either party at such other address as either party hereto may hereafter designate in writing to
the other. Any such notice shall be deemed effective upon receipt thereof by the addressee. 

  
 -3- 

 9. Choice of Law; Jurisdiction; Venue. This Agreement shall be governed by and
construed in accordance with the internal laws of the State of Delaware applicable to contracts made and performed wholly within the State of Delaware, without giving effect to the conflict of laws provisions thereof. Any suit, action or proceeding
with respect to this Agreement (or any provision incorporated by reference), or any judgment entered by any court in respect of any thereof, shall be brought in any court of competent jurisdiction in the State of Delaware, and each of Participant,
the Company, and any transferees who hold Shares pursuant to a valid Assignment, hereby submits to the exclusive jurisdiction of such courts for the purpose of any such suit, action, proceeding, or judgment. Each of Participant, the Company, and any
transferees who hold Shares pursuant to a valid Assignment hereby irrevocably waives (a) any objections which it may now or hereafter have to the laying of the venue of any suit, action, or proceeding arising out of or relating to this
Agreement brought in any court of competent jurisdiction in the State of Delaware, (b) any claim that any such suit, action, or proceeding brought in any such court has been brought in any inconvenient forum and (c) any right to a jury
trial. 
 10. Shares Subject to Plan; Amendment. By entering into this Agreement, Participant agrees and acknowledges that Participant
has received and read a copy of the Plan. The Options granted hereunder are subject to the Plan. The terms and provisions of the Plan, as it may be amended from time to time, are hereby incorporated herein by reference. In the event of a conflict
between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail. The Committee may waive any conditions or rights under, amend any terms of, or alter,
suspend, discontinue, cancel or terminate this Agreement, but no such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination shall materially adversely affect the rights of Participant hereunder without the consent of
Participant. Notwithstanding anything in this Agreement or the Plan to the contrary, the Company may amend and update the number of Options in the Equity Schedule set forth on the Signature Page hereto prior to or following the effective date of the
IPO. 
 11. Section 409A. It is the Company’s intent that payments under this Agreement are exempt from Section 409A of the
Internal Revenue Code of 1986, as amended, and that the Agreement be administered accordingly. 
 12. Entire Agreement. This Agreement
is the final, complete and exclusive agreement of the parties with respect to its subject matter and supersedes and merges all prior or contemporaneous discussions or agreements, whether written or oral, regarding the subject matter of this
Agreement. 
 13. Severability. In the event that any provision of this Agreement or application thereof to anyone or under any
circumstance is found to be invalid or unenforceable in any jurisdiction to any extent for any reason, such invalidity or unenforceability shall not affect any other provision or application of this Agreement which can be given effect without the
invalid or unenforceable provision or application and shall not invalidate or render unenforceable such provision or application in any other jurisdiction. 

14. Counterparts. This Agreement may be executed in several counterparts, each of which is an original and all of which shall constitute
one instrument. It shall not be necessary in making proof of this Agreement or any counterpart hereof to produce or account for any of the other counterparts. 

[Signatures on next page.] 

  
 -4- 

 IN WITNESS WHEREOF, Participant acknowledges and accepts the terms of this Agreement, which
shall be effective as of the date set forth below and countersignature by the Company. 
  

			
	Participant
	
	  

	 Name:
	 	
		
	 Dated:
	 	  

 [Signature Page - Replacement Award for Profits Interests of AOT Building Products, L.P.] 

 Agreement acknowledged and confirmed: 

 

			
	THE AZEK COMPANY INC.
		
	By:	 	  

	Name:	 	
	Title:	 	

 Equity Schedule1 

Name: 
 Date of Acquisition of Profits Interests:

 Date of Grant: 
 Vesting Reference Date:

  

																					
	 Profits Interests
	 	  	Shares	  	Options	 
	 	  	Number
of
Vested
Profits
Interests	 	  	Number
of
Unvested
Profits
Interests	 	  	Number
of
Shares	  	Number
of Shares
of
Restricted
Stock	  	Number
of
Vested
Options	 	  	Number
of
Unvested
Options	 
	 Time Vested Profits Interests
	  				  				  		  				  			
	 Performance Vested Profits Interests
	  	 	—	 	  				  	—	  	 	—	 	  			
	 Total
	  				  				  		  				  			

  

	1 	 Additional equity schedules to be added for Participants with more than one Profits Interests award.

  
 [Signature Page -
Replacement Award for Profits Interests of AOT Building Products, L.P.] 

 Schedule I 

Vesting Terms – Options 

(a) Vested Options. The Options issued in respect of vested Profits Interests (as reflected in the Equity Schedule on the Signature
Page) will be fully vested on the Date of Grant. 
 (a) Time-Based Vesting Shares. The Options issued in respect of unvested time
vested Profits Interests (as reflected in the Equity Schedule on the Signature Page) will continue to vest in the same proportion, and on the same schedule and terms (including forfeiture), as such time vested Profits Interests would have vested
under the terms of the LP Interest Agreement. The Participant’s LP Interest Agreement(s) are attached as Exhibit B. 
 (b)
Performance-Based Vesting Shares. The Options issued in respect of unvested performance vested Profits Interests (as reflected in the Equity Schedule on the Signature Page) will continue to vest in the same proportion, and on the same terms
(including forfeiture), as such performance vested Profits Interests would have vested under the terms of the LP Interest Agreement, except as provided below. The Participant’s LP Interest Agreement(s) are attached as Exhibit B. 

(A) For purposes of the definition of “Proceeds,” the “Fair Value” of the Sponsors’ Shares (regardless of whether such
Shares are freely tradable and marketable) shall be measured as follows: 
 (i) On expiration of the Sponsors’ lockup, the Fair Value
of the Sponsors’ Shares will be measured based on the number of Shares owned by the Sponsors multiplied by the volume-weighted average trading price for the 45 trading days prior to the expiration of the Sponsors’ lockup (the
“Post-Lockup Proceeds”). The performance-based Options will vest to the extent that both (x) the Post-Lockup Proceeds results in the applicable performance criteria being met and (y) the closing price of a
Share on the last trading day of the Sponsors’ lockup period multiplied by the number of Shares owned by the Sponsors results in the applicable performance criteria being met. 

(ii) To the extent that any of the performance-based vesting conditions were not met at the end of the Sponsors’ lockup period in
accordance with the prior paragraph, then the Fair Value of the Sponsors’ Shares will be measured after the end of each full calendar quarter that follows the end of the Sponsors’ lockup period (each, a “Measurement
Date”). The performance-based Options will vest on a Measurement Date to the extent that the applicable performance condition is met based on the volume-weighted average trading price of a Share over any consecutive 45 trading day period
during such full calendar quarter. 
 (B) The Compensation Committee of the Board of Directors may, in its sole discretion, measure
performance under this paragraph more frequently than each quarter end and vest performance-based Options to the extent that performance conditions are met. 

(C) Any employee whose employment terminates due to death or Disability, or whose employment is terminated other than for Cause (as such terms
are defined in the Plan), during a quarter will remain eligible to vest in any performance-based Options that vest as a result of performance in that quarter. 

 Exhibit A 

LP Interest Agreement(s) 

(Enclosed) 

 Exhibit B 

LOCK-UP LETTER AGREEMENT 

BARCLAYS CAPITAL INC. 

BOFA SECURITIES, INC. 

GOLDMAN SACHS & CO. LLC 

JEFFERIES LLC 
 As Representatives of the several

 Underwriters named in Schedule I of the Underwriting Agreement,

c/o Barclays Capital Inc. 
 745 Seventh Avenue 

New York, New York 10019 
 Ladies and Gentlemen: 

The undersigned understands that you and certain other firms (the “Underwriters”) propose to enter into an
Underwriting Agreement (the “Underwriting Agreement”) providing for the purchase by the Underwriters of shares (the “Stock”) of Class A Common Stock, par value $0.001 per share (the
“Common Stock”), of The AZEK Company Inc., a Delaware corporation (the “Company”), and that the Underwriters propose to reoffer the Stock to the public (the “Offering”). 

In consideration of the execution of the Underwriting Agreement by the Underwriters, and for other good and valuable consideration, the
undersigned hereby irrevocably agrees that, without the prior written consent of Barclays Capital Inc. and BofA Securities, Inc., on behalf of the Underwriters, the undersigned will not, directly or indirectly, (1) offer for sale, sell, pledge,
or otherwise dispose of (or enter into any transaction or device that is designed to, or would be expected to, result in the disposition by any person at any time in the future of) any shares of Common Stock (including, without limitation, shares of
Common Stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of Common Stock that may be issued upon exercise of any options or
warrants) or securities convertible into or exercisable or exchangeable for Common Stock, (2) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of
ownership of shares of Common Stock, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise, (3) make any demand for or
exercise any right or cause to be publicly filed a registration statement, including any amendments thereto, with respect to the registration of any shares of Common Stock or securities convertible into or exercisable or exchangeable for Common
Stock or any other securities of the Company, or (4) publicly disclose the intention to do any of the foregoing for a period commencing on the date hereof and ending on the 180th day after the date of the Prospectus relating to the Offering
(such 180-day period, the “Lock-Up Period”). 

 The foregoing paragraph shall not apply to (a) shares of Common Stock acquired from the
Underwriters in the Offering or transactions relating to shares of Common Stock or other securities acquired in the open market after the completion of the Offering, (b) transfers of shares of Common Stock or any security convertible into
Common Stock as a bona fide gift or gifts, (c) sales or other dispositions of shares of any class of the Company’s capital stock, in each case that are made exclusively between and among the undersigned or members of the undersigned’s
family (including to any trust, limited partnership, limited liability company or other entity for the direct or indirect benefit of the undersigned or any members of the undersigned’s family), or affiliates of the undersigned, including its
subsidiaries, partners (if a partnership), members (if a limited liability company), stockholders (if a corporation) or any investment fund or other entity controlling, controlled by, managing, or managed by or under common control with the
undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), (d) transfers of
shares of Common Stock or any security convertible into Common Stock by will, testamentary document or intestate succession upon the death of the undersigned; provided that it shall be a condition to any transfer (i) pursuant to clauses
(b)-(d) that the transferee/donee agrees to be bound by the terms of this Lock-Up Letter Agreement (including, without limitation, the restrictions set forth in the preceding sentence) to the same extent as if
the transferee/donee were a party hereto, (ii) pursuant to clauses (b)-(d) that each party (donor, donee, transferor or transferee) shall not be required by law (including without limitation the disclosure requirements of the Securities Act of
1933, as amended (the Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) to make, and shall agree to not voluntarily make, any filing or public announcement of the
transfer or disposition prior to the expiration of the 180-day period referred to above (other than any required filed on Form 5), and (iii) pursuant to clauses (b) and (c) that the undersigned
notifies Barclays Capital Inc. and BofA Securities, Inc. at least two business days prior to the proposed transfer or disposition, (f) the exercise (including cashless exercise) of warrants or the exercise of stock options granted pursuant to
the Company’s stock option/incentive plans or otherwise outstanding on the date hereof; provided, that the restrictions shall apply to shares of Common Stock issued upon such exercise or conversion, (g) the establishment of any
contract, instruction or plan that satisfies all of the requirements of Rule 10b5-1 (a “Rule 10b5-1 Plan”) under the Exchange Act;
provided, however, that no sales of Common Stock or securities convertible into, or exchangeable or exercisable for, Common Stock, shall be made pursuant to a Rule 10b5-1 Plan prior to the
expiration of the Lock-Up Period; provided further, that the Company is not required to report the establishment of such Rule 10b5-1 Plan in any public
report or filing with the Commission under the Exchange Act during the lock-up period and does not otherwise voluntarily effect any such public filing or report regarding such Rule 10b5-1 Plan, (h) any demands or requests for, the exercise of any right with respect to, or the taking of any action in preparation of, the registration by the Company under the Securities Act of the
undersigned’s shares of Common Stock, provided that no transfer of the undersigned’s shares of Common Stock registered pursuant to the exercise of any such right and no registration statement shall be publicly filed under the Securities
Act with respect to any of the undersigned’s shares of Common Stock during the Lock-Up Period, (i) any transfer pursuant to a bona fide third party tender or exchange offer made to all holders of the
Common Stock, merger, consolidation or other similar transaction involving a change of control (as defined below) of the Company, including voting in favor of any such transaction or taking any other action in connection with such transaction,
(provided that in the event that such tender 

 
offer, merger, consolidation or other such transaction is not completed, the undersigned shall remain subject to the restrictions contained in this Lock-Up
Letter Agreement), (j) transfers to the Company for the purpose of satisfying any tax withholding obligations (including estimated taxes) due as a result of the exercise of options or as a result of the vesting of or upon the receipt of equity
awards held by the undersigned, (k) the repurchase of Common Stock or securities convertible into Common Stock by the Company pursuant to equity award agreements or other contractual arrangements providing for the right of said repurchase in
connection with the termination of the undersigned’s employment or service with the Company (l) the exchange of shares of Common Stock for shares of Class B common stock or the exchange of shares of Class B common stock for
Common Stock (provided that the Common Stock or Class B common stock issued as a result of such exchange is subject to this Lock-Up Letter Agreement) and (m) transfers of shares of Common Stock or
any security convertible into Common Stock by operation of law or pursuant to an order of a court or regulatory agency, provided, however, that for purposes of clauses (j) through (m), if the undersigned is legally required during
the Lock-Up Period to file a report under the Exchange Act reporting a reduction in beneficial ownership of shares of Common Stock to the Company, the undersigned shall include a statement in such report
clearly indicating the nature and conditions of such transfer. For purposes of clause (i) above, “change of control” shall mean the consummation of any bona fide third party tender or exchange offer, merger, purchase, consolidation or
other similar transaction the result of which is that any “person” (as defined in Section 13(d)(3) of the Exchange Act), or group of persons, becomes the beneficial owner (as defined in Rules
13d-3 and 13d-5 of the Exchange Act) of a majority of total voting power of the voting stock of the Company. 

If the undersigned is an officer or director of the Company, (i) the undersigned agrees that the foregoing provisions shall be equally
applicable to any issuer-directed Stock, as referred to in FINRA Rule 5131(d)(2)(A) that the undersigned may purchase in the Offering pursuant to an allocation of Stock that is directed in writing by the Company, (ii) Barclays Capital Inc. and
BofA Securities, Inc., agree that, at least three business days before the effective date of any release or waiver of the foregoing restrictions in connection with a transfer of shares of Common Stock, Barclays Capital Inc. or BofA Securities, Inc.
will notify the Company of the impending release or waiver and (iii) the Company has agreed in the Underwriting Agreement to announce the impending release or waiver by issuing a press release through a major news service (as referred to in
FINRA Rule 5131(d)(2)(B)) at least two business days before the effective date of the release or waiver. Any release or waiver granted by Barclays Capital Inc. and BofA Securities, Inc. hereunder to any such officer or director shall only be
effective two business days after the publication date of such press release. The provisions of this paragraph will not apply if both (a) the release or waiver is effected solely to permit a transfer not for consideration, and (b) the
transferee has agreed in writing to be bound by the same terms described in this letter that are applicable to the transferor, to the extent and for the duration that such terms remain in effect at the time of the transfer. 

In furtherance of the foregoing, the Company and its transfer agent are hereby authorized to decline to make any transfer of securities if
such transfer would constitute a violation or breach of this Lock-Up Letter Agreement. 
 It is
understood that, if the Company notifies the Underwriters that it does not intend to proceed with the Offering, if the Underwriting Agreement does not become effective, or if the Underwriting Agreement (other than the provisions thereof which
survive termination) shall terminate or be terminated prior to payment for and delivery of the Stock, the undersigned will be released from its obligations under this Lock-Up Letter Agreement. 

 The undersigned understands that the Company and the Underwriters will proceed with the
Offering in reliance on this Lock-Up Letter Agreement. 
 Whether or not the Offering actually
occurs depends on a number of factors, including, without limitation, market conditions. Any Offering will only be made pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Underwriters.

 The undersigned hereby consents to receipt of this Lock-Up Letter Agreement in electronic form
and understands and agrees that this Lock-Up Letter Agreement may be signed electronically. In the event that any signature is delivered by facsimile transmission, electronic mail or otherwise by electronic
transmission evidencing an intent to sign this Lock-Up Letter Agreement, such facsimile transmission, electronic mail or other electronic transmission shall create a valid and binding obligation on the
undersigned with the same force and effect as if such signature were an original execution, and delivery of this Lock-Up Letter Agreement by facsimile transmission, electronic mail or other electronic
transmission is legal, valid and binding for all purposes. 
 This Lock-Up Letter Agreement shall
automatically terminate upon the earliest to occur, if any, of (1) the termination of the Underwriting Agreement before the sale of any Stock to the Underwriters, (2) [•], in the event that the Underwriting Agreement has not been executed
by that date, provided that the Company may, by written notice to the undersigned prior to such date, extend such date for a period of up to three additional months, (3) the filing by the Company of an application to withdraw the registration
statement related to the Offering and (4) the Underwriters notifying the Company, or the Company notifying the Underwriters, in writing, prior to the execution of the Underwriting Agreement, that it has determined not to proceed with the
Offering.EX-10.37

 Exhibit 10.37 

THE AZEK COMPANY INC. 

2020 OMNIBUS INCENTIVE COMPENSATION PLAN 

IPO NONQUALIFIED STOCK OPTION AWARD AGREEMENT 

This Nonqualified Stock Option Award Agreement (this “Award Agreement”) evidences an award of nonqualified stock
options (“Options”) by The AZEK Company Inc., a Delaware corporation (“AZEK”) under The AZEK Company Inc. 2020 Omnibus Incentive Compensation Plan (the “Plan”). Capitalized
terms not defined in the Award Agreement have the meanings given to them in the Plan. 
  

			
	Name of Grantee:	  	Gary Hendrickson (the “Grantee”).
		
	Grant Date:	  	__________ (the “Grant Date”).
		
	Number of Options:	  	 ______________________.
  

Each Option represents the right to purchase one share of common stock, par value $0.001 (each, a “Share”), of AZEK at the Exercise
Price set forth below on the terms and conditions set forth herein.

		
	Exercise Price:	  	The Exercise Price will be $_______ (the “Exercise Price”).
		
	Vesting Dates:	  	 A number of Options equal to 25% of the Options (rounded to the nearest whole number) shall vest on each of the first three anniversaries of
the closing of AZEK’s initial public offering (“IPO”), and the remaining Options will vest on the fourth anniversary of the closing of AZEK’s IPO (each such anniversary, a “Vesting
Date”).
  
 The Options will vest only if the Grantee is, and has been,
continuously serving as a Non-Employee Director on AZEK’s board of directors (the “Board”) from the Grant Date through the applicable Vesting Date, and any unvested Options will be
forfeited upon the termination of the Grantee’s service as a Non-Employee Director for any reason.
  

Notwithstanding the foregoing, upon a Change in Control, any outstanding, unvested Options will be treated in accordance with the Plan.

		
	Term:	  	The latest date the Option will expire is on the tenth anniversary of the Grant Date (the “Expiration Date”). However, in the event the Grantee’s service terminates for any reason prior to the Expiration
Date, vested Options shall remain exercisable for the period as set forth below, unless the Board determines otherwise:

  
 -1- 

			
	  
	  	 •  Upon a termination of the Grantee’s service for any reason other than
for Cause, Disability or death, the Grantee may exercise the Options until the date that is 90 days following the date of the termination of service, but in no event later than the Expiration Date.

 
 •  Upon a termination of the
Grantee’s service for Cause, the Options shall expire and immediately cease to be exercisable upon the date of the termination of service.
  

•  Upon a termination of the Grantee’s service due to death or Disability, the Options shall
expire one year after the date of the Grantee’s termination, but in no event later than the Expiration Date.

		
	Exercise of Option:	  	 Vested Options may be exercised by submitting to AZEK a written notice specifying the number of Options to be exercised accompanied by the
full Exercise Price in cash or by certified or official bank check or in another form as determined by the Compensation Committee of the Board (the “Committee”). The Committee may also make arrangements for the cashless
exercise of an Option.
  
 As soon as reasonably practicable following AZEK’s
determination that the Option has been validly exercised, AZEK will issue the relevant number of Shares to be allocated to the Grantee, subject to applicable tax withholding as provided in Section 3.2 of the Plan.

		
	Regular Fees:	  	This grant of Options will be in addition to any regular fees to which you are entitled for service on the Board (or a committee of the Board), but will be in lieu of (i) any additional compensation to which you would otherwise
be entitled for service as Chair of the Board until the Options are vested in full and (ii) any inaugural grant to members of the Board in connection with the Company’s initial public offering.
		
	Section 409A:	  	It is AZEK’s intent that payments under this Award Agreement are exempt from Section 409A of the Internal Revenue Code of 1986, as amended, and that the Award Agreement be administered accordingly.
		
	Tax Representations; Withholding:	  	The Grantee is advised to review with his/her own tax advisors the federal, state and local tax consequences of receiving and exercising the Options. The Grantee hereby represents to AZEK that he/she is relying solely on such
advisors and not on any statements or representations of AZEK, its Affiliates or any of their respective agents. If, in connection with the exercise of the Options, AZEK is required to withhold any amounts by reason of any federal, state or local
tax, such withholding shall be effected in accordance with Section 3.2 of the Plan.

			
		
	Transfer Restrictions:	  	The Grantee may not sell, exchange, transfer, assign, pledge, hypothecate or otherwise encumber the Options or the Grantee’s right under the Options to receive Shares, other than to the extent provided in Section 3.5 of
the Plan.
		
	Amendment:	  	The Committee reserves the right at any time to amend the terms and conditions set forth in this Award Agreement, except that the Committee shall not make any amendment in a manner unfavorable to the Grantee (other than if
immaterial), without the Grantee’s consent. Any amendment of this Award Agreement shall be in writing and signed by an authorized member of the Committee or a person or persons designated by the Committee.
		
	Governing Law:	  	This Award Agreement shall be deemed to be made under, and in all respects be interpreted, construed and governed by and in accordance with, the laws of the State of [Delaware] without regard to conflict of law principles.
		
	All Other Terms:	  	As set forth in the Plan.

 The Plan is incorporated herein by reference. Except as otherwise set forth in the Award Agreement, the Award
Agreement and the Plan constitute the entire agreement and understanding of the parties with respect to the Options. In the event that any provision of the Award Agreement is inconsistent with the Plan, the terms of the Plan will control. By
accepting this Award, the Grantee agrees to be subject to the terms and conditions of the Plan. 
 This Award Agreement may be executed in
counterparts, which together will constitute one and the same original. 

 IN WITNESS WHEREOF, the parties have caused this Award Agreement to be duly executed
and effective as of the Grant Date. 
  

			
	THE AZEK COMPANY INC.
		
	By:	 	 
		 	Name:
		 	Title:
	
	Acknowledged and Agreed:
	
	  

	Gary Hendrickson

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}]]